New TB Blood Test Could Help Early Detection
A TB blood test identifies a bacterial marker to distinguish between active and latent tuberculosis infections.
A TB blood test identifies a bacterial marker to distinguish between active and latent tuberculosis infections.
Analyzing respiratory patterns through machine learning models improved early identification of bronchopulmonary dysplasia (BPD) in preterm infants.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
Olorofim may provide a treatment option for patients with disseminated Valley Fever who have failed standard therapies.
Female emergency department physicians ordered 3% to 5% more imaging and laboratory tests and admitted 3% to 5% more patients.
Zidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.